+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Generic Drugs Market by Product Type (Over-the-Counter (OTC) Generic Drugs, Prescription Generic Drugs), Drug Class (Analgesics, Antibiotics, Antidepressants), Route of Administration, Patient Type, Therapeutic Application, Distribution Channel - Global Forecast 2025-2030- Product Image
Generic Drugs Market by Product Type (Over-the-Counter (OTC) Generic Drugs, Prescription Generic Drugs), Drug Class (Analgesics, Antibiotics, Antidepressants), Route of Administration, Patient Type, Therapeutic Application, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Generic Drugs Market by Product Type (Over-the-Counter (OTC) Generic Drugs, Prescription Generic Drugs), Drug Class (Analgesics, Antibiotics, Antidepressants), Route of Administration, Patient Type, Therapeutic Application, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888623
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The generic drugs market is experiencing dynamic transformation as global healthcare systems prioritize affordability, access, and efficiency. Senior executives and industry stakeholders increasingly leverage generics to optimize resource deployment, ensure supply chain sustainability, and strengthen their strategic market positions.

Market Snapshot: Generic Drugs Market Size & Growth

The Generic Drugs Market grew from USD 415.28 billion in 2024 to USD 451.61 billion in 2025. It is expected to continue growing at a CAGR of 9.08%, reaching USD 699.65 billion by 2030. Surging demand for cost-effective pharmaceuticals, an evolving regulatory landscape, and intensifying competition are driving this robust expansion. Stakeholders recognize the imperative to streamline development, distribution, and regulatory compliance as the market matures across both established and emerging geographies.

Scope & Segmentation

This comprehensive research outlines the full landscape of the generic drugs market, with deep coverage of key segments, application areas, and global regions. The analysis highlights drivers and barriers across product varieties, user demographics, therapeutic applications, and distribution models, equipping leaders to pinpoint targeted growth avenues.

  • Product Types: Over-the-counter (OTC) generic drugs, Prescription generic drugs
  • Drug Classes: Analgesics, Antibiotics, Antidepressants, Antidiabetics, Antihistamines, Antihypertensives
  • Routes of Administration: Inhalations, Injectables, Oral, Topical
  • Patient Types: Adult, Geriatric, Pediatric
  • Therapeutic Applications: Anti-infectives, Cardiovascular, Central nervous system (CNS), Diabetes, Oncology, Respiratory
  • Distribution Channels: Hospital pharmacies, Retail pharmacies, Online pharmacies
  • Geographic Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, and others), Asia-Pacific (including China, India, Japan, Australia, and others)
  • Notable Market Participants: Companies include Abbott Laboratories, Alembic Pharmaceuticals Limited, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, and others

Key Takeaways: Strategic Insights in the Generic Drugs Market

  • Generic pharmaceuticals are instrumental in reducing healthcare expenditures and increasing therapy accessibility across public and private sectors.
  • Increased regulatory harmonization and expedited approval processes support rapid entry of new generics, especially after key patent expirations.
  • Collaborative partnerships—between manufacturers, contract organizations, and healthcare providers—are enabling both innovation and operational efficiencies.
  • Digitization of supply chains and advanced analytics ensure real-time tracking, supply continuity, and adaptive risk mitigation.
  • Emerging markets are contributing to significant growth opportunities, although variable infrastructure and regulatory maturity present ongoing challenges.
  • Manufacturers are differentiating through product quality, value-based procurement models, and patient-centric services that support adherence and clinical outcomes.

Tariff Impact: 2025 Adjustments and Strategic Response

Recent tariffs introduced in 2025 are affecting costs, supply chain configurations, and sourcing strategies for active pharmaceutical ingredients. Companies are investing in domestic facilities and revisiting supplier contracts to shield operations from geopolitical volatility. Distribution partners, including retail and hospital pharmacies, are reevaluating procurement terms and adopting total cost of ownership analyses to maintain sustainable margins. Regulatory scrutiny of these cost-management shifts—and enhanced compliance programs—are impacting how organizations reconfigure their supply networks and contract manufacturing relationships.

Methodology & Data Sources

The research methodology integrates primary interviews with senior executives and regulators, and secondary analysis of public regulatory filings and industry databases. Robust data triangulation, scenario modeling, and expert validation underpin all strategic findings, ensuring the report’s accuracy and relevance.

Why This Report Matters

  • Provides senior leaders with actionable insights to anticipate industry shifts and calibrate supply chain and product strategies.
  • Enables informed decision-making around investments in technology, market entry, and regulatory engagement.
  • Equips manufacturers and payers to adapt to evolving market access requirements and strengthen competitive advantage.

Conclusion

As the generic drugs landscape evolves, data-driven decisions, operational agility, and cross-sector collaboration are vital for sustained market leadership. This report equips stakeholders with the strategic clarity needed to seize opportunities and optimize patient-centered value.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increased uptake of biosimilar oncology drugs following patent expirations in key markets
5.2. Strategic pricing pressures from national health systems accelerating off-patent drug cost reductions
5.3. Rapid expansion of complex generic approvals for inhalation and transdermal drug delivery systems
5.4. Integration of artificial intelligence in generic drug formulation development and manufacturing processes
5.5. Growing partnerships between generic manufacturers and contract development organizations to optimize capacity
5.6. Regulatory harmonization efforts streamlining generic drug approval across multiple emerging markets
5.7. Surge in compulsory licensing negotiations enabling low-cost generic antivirals in developing nations
5.8. Increasing vertical consolidation among generic drug producers to mitigate API supply chain disruptions
5.9. Emergence of digital therapeutics combined with generic medications for chronic disease management
5.10. Consumer preference shift towards at-home generic diagnostic test kits accelerated by telehealth adoption
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Generic Drugs Market, by Product Type
8.1. Introduction
8.2. Over-the-Counter (OTC) Generic Drugs
8.3. Prescription Generic Drugs
9. Generic Drugs Market, by Drug Class
9.1. Introduction
9.2. Analgesics
9.3. Antibiotics
9.4. Antidepressants
9.5. Antidiabetics
9.6. Antihistamines
9.7. Antihypertensives
10. Generic Drugs Market, by Route of Administration
10.1. Introduction
10.2. Inhalations
10.3. Injectables
10.4. Oral
10.5. Topical
11. Generic Drugs Market, by Patient Type
11.1. Introduction
11.2. Adult
11.3. Geriatric
11.4. Pediatric
12. Generic Drugs Market, by Therapeutic Application
12.1. Introduction
12.2. Anti-infectives
12.3. Cardiovascular
12.4. Central Nervous System (CNS)
12.5. Diabetes
12.6. Oncology
12.7. Respiratory
13. Generic Drugs Market, by Distribution Channel
13.1. Introduction
13.2. Offline
13.2.1. Hospital Pharmacies
13.2.2. Retail Pharmacies
13.3. Online Pharmacies
14. Americas Generic Drugs Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Generic Drugs Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Generic Drugs Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. Alembic Pharmaceuticals Limited
17.3.3. Alkem Laboratories Limited
17.3.4. Amneal Pharmaceuticals, Inc.
17.3.5. Aspen Pharmacare Holdings Limited
17.3.6. Aurobindo Pharma Limited
17.3.7. Bausch Health Companies Inc.
17.3.8. Baxter International Inc.
17.3.9. Biocon Limited
17.3.10. Cipla Limited
17.3.11. Dr. Reddy’s Laboratories Ltd.
17.3.12. Eli Lilly and Company
17.3.13. Endo, Inc.
17.3.14. Fresenius SE & Co. KGaA
17.3.15. GlaxoSmithKline PLC
17.3.16. Glenmark Pharmaceuticals Limited
17.3.17. Hikma Pharmaceuticals PLC.
17.3.18. Intas Pharmaceuticals Ltd.
17.3.19. Krka, d. d.
17.3.20. Lupin Limited
17.3.21. Pfizer, Inc.
17.3.22. Sandoz Group AG
17.3.23. Sanofi SA
17.3.24. STADA Arzneimittel AG
17.3.25. Sun Pharmaceutical Industries Limited
17.3.26. Teva Pharmaceutical Industries Ltd.
17.3.27. Viatris Inc.
17.3.28. Zydus Lifesciences Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. GENERIC DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GENERIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GENERIC DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GENERIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES GENERIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GENERIC DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. GENERIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. GENERIC DRUGS MARKET: RESEARCHAI
FIGURE 28. GENERIC DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 29. GENERIC DRUGS MARKET: RESEARCHCONTACTS
FIGURE 30. GENERIC DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GENERIC DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENERIC DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GENERIC DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GENERIC DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GENERIC DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GENERIC DRUGS MARKET SIZE, BY OVER-THE-COUNTER (OTC) GENERIC DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GENERIC DRUGS MARKET SIZE, BY OVER-THE-COUNTER (OTC) GENERIC DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GENERIC DRUGS MARKET SIZE, BY PRESCRIPTION GENERIC DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GENERIC DRUGS MARKET SIZE, BY PRESCRIPTION GENERIC DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GENERIC DRUGS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GENERIC DRUGS MARKET SIZE, BY ANALGESICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GENERIC DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GENERIC DRUGS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GENERIC DRUGS MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GENERIC DRUGS MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GENERIC DRUGS MARKET SIZE, BY ANTIDIABETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GENERIC DRUGS MARKET SIZE, BY ANTIDIABETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GENERIC DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GENERIC DRUGS MARKET SIZE, BY ANTIHISTAMINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GENERIC DRUGS MARKET SIZE, BY ANTIHYPERTENSIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GENERIC DRUGS MARKET SIZE, BY ANTIHYPERTENSIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GENERIC DRUGS MARKET SIZE, BY INHALATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GENERIC DRUGS MARKET SIZE, BY INHALATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GENERIC DRUGS MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GENERIC DRUGS MARKET SIZE, BY INJECTABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GENERIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GENERIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GENERIC DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GENERIC DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GENERIC DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GENERIC DRUGS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GENERIC DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GENERIC DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GENERIC DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GENERIC DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GENERIC DRUGS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GENERIC DRUGS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GENERIC DRUGS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GENERIC DRUGS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GENERIC DRUGS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM (CNS), BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GENERIC DRUGS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM (CNS), BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GENERIC DRUGS MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GENERIC DRUGS MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GENERIC DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GENERIC DRUGS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GENERIC DRUGS MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GENERIC DRUGS MARKET SIZE, BY RESPIRATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL GENERIC DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL GENERIC DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL GENERIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL GENERIC DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL GENERIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES GENERIC DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES GENERIC DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 105. CANADA GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 106. CANADA GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 107. CANADA GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 108. CANADA GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 109. CANADA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 110. CANADA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 111. CANADA GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. CANADA GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. CANADA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 116. CANADA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 117. CANADA GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 118. CANADA GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 119. MEXICO GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 122. MEXICO GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 123. MEXICO GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. MEXICO GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. MEXICO GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 126. MEXICO GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. MEXICO GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. MEXICO GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. MEXICO GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. MEXICO GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 132. MEXICO GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 191. GERMANY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 192. GERMANY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 193. GERMANY GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 194. GERMANY GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 195. GERMANY GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. GERMANY GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. GERMANY GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 198. GERMANY GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 199. GERMANY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. GERMANY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. GERMANY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. GERMANY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. GERMANY GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 204. GERMANY GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 205. FRANCE GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. FRANCE GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. FRANCE GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 208. FRANCE GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 209. FRANCE GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. FRANCE GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. FRANCE GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 212. FRANCE GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 213. FRANCE GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. FRANCE GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. FRANCE GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. FRANCE GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. FRANCE GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 218. FRANCE GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 233. ITALY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 234. ITALY GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 235. ITALY GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 236. ITALY GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 237. ITALY GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. ITALY GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. ITALY GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 240. ITALY GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 241. ITALY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. ITALY GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. ITALY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. ITALY GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. ITALY GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 246. ITALY GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 247. SPAIN GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. SPAIN GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. SPAIN GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 250. SPAIN GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 251. SPAIN GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. SPAIN GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. SPAIN GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 254. SPAIN GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 255. SPAIN GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. SPAIN GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. SPAIN GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. SPAIN GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. SPAIN GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 260. SPAIN GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 288. SAUDI ARABIA GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 296. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 298. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 302. SOUTH AFRICA GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 303. DENMARK GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 304. DENMARK GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 305. DENMARK GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 306. DENMARK GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 307. DENMARK GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 308. DENMARK GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 309. DENMARK GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 310. DENMARK GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 311. DENMARK GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 312. DENMARK GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 313. DENMARK GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. DENMARK GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. DENMARK GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 316. DENMARK GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 321. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 322. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 323. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 324. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 325. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 326. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 327. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 330. NETHERLANDS GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 331. QATAR GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 332. QATAR GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 333. QATAR GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 334. QATAR GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 335. QATAR GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 336. QATAR GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 337. QATAR GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 338. QATAR GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 339. QATAR GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 340. QATAR GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 341. QATAR GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 342. QATAR GENERIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 343. QATAR GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2018-2024 (USD MILLION)
TABLE 344. QATAR GENERIC DRUGS MARKET SIZE, BY OFFLINE, 2025-2030 (USD MILLION)
TABLE 345. FINLAND GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 346. FINLAND GENERIC DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 347. FINLAND GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 348. FINLAND GENERIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 349. FINLAND GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 350. FINLAND GENERIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 351. FINLAND GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
TABLE 352. FINLAND GENERIC DRUGS MARKET SIZE, BY PATIENT TYPE, 2025-2030 (USD MILLION)
TABLE 353. FINLAND GENERIC DRUGS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TA

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Generic Drugs market report include:
  • Abbott Laboratories
  • Alembic Pharmaceuticals Limited
  • Alkem Laboratories Limited
  • Amneal Pharmaceuticals, Inc.
  • Aspen Pharmacare Holdings Limited
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc.
  • Baxter International Inc.
  • Biocon Limited
  • Cipla Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Eli Lilly and Company
  • Endo, Inc.
  • Fresenius SE & Co. KGaA
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Hikma Pharmaceuticals PLC.
  • Intas Pharmaceuticals Ltd.
  • Krka, d. d.
  • Lupin Limited
  • Pfizer, Inc.
  • Sandoz Group AG
  • Sanofi SA
  • STADA Arzneimittel AG
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Zydus Lifesciences Limited

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 451.61 Billion
Forecasted Market Value ( USD ) by 2030 $ 699.65 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

United States Generic Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

United States Generic Drugs Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • United States
From
North America Generic Drugs Market Report and Forecast 2024-2032 - Product Image

North America Generic Drugs Market Report and Forecast 2024-2032

  • Report
  • 140 Pages
  • North America
From
Generic Drugs - Global Strategic Business Report - Product Image

Generic Drugs - Global Strategic Business Report

  • Report
  • 711 Pages
  • Global
From
Chemical Generic Drugs Market by Dosage Form (Capsules, Injectables, Oral Solutions), Route of Administration (Inhalation, Nasal, Ophthalmic), Therapeutic Class, End User, Sales Channel - Global Forecast 2025-2030 - Product Image

Chemical Generic Drugs Market by Dosage Form (Capsules, Injectables, Oral Solutions), Route of Administration (Inhalation, Nasal, Ophthalmic), Therapeutic Class, End User, Sales Channel - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Generic Injectables Market by Dimension Query Chat Segmentation (Distribution Channel, Dosage Form, Drug Class) - Global Forecast 2025-2030 - Product Image

Generic Injectables Market by Dimension Query Chat Segmentation (Distribution Channel, Dosage Form, Drug Class) - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From

About the Generic Drugs Market

The Generic Drugs market is a segment of the pharmaceutical industry that focuses on the production and sale of generic drugs. Generic drugs are copies of brand-name drugs that have the same active ingredients, dosage form, strength, route of administration, safety, efficacy, and intended use as the original drug. Generic drugs are typically much cheaper than their brand-name counterparts, making them a popular choice for consumers. Generic drugs are produced by a variety of companies, including large pharmaceutical companies, small generic drug manufacturers, and even generic drug divisions of brand-name drug companies. Generic drug companies must meet the same standards of quality, safety, and efficacy as brand-name drug companies. Some of the major companies in the Generic Drugs market include Teva Pharmaceuticals, Mylan, Sandoz, Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Lupin. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.